+Search query
-Structure paper
Title | ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma. |
---|---|
Journal, issue, pages | Nature, Vol. 594, Page 418-423, Year 2021 |
Publish date | Jun 16, 2020 (structure data deposition date) |
Authors | Yen, I. / Shanahan, F. / Lee, J. / Hong, Y.S. / Shin, S.J. / Moore, A.R. / Sudhamsu, J. / Chang, M.T. / Bae, I. / Dela Cruz, D. ...Yen, I. / Shanahan, F. / Lee, J. / Hong, Y.S. / Shin, S.J. / Moore, A.R. / Sudhamsu, J. / Chang, M.T. / Bae, I. / Dela Cruz, D. / Hunsaker, T. / Klijn, C. / Liau, N.P.D. / Lin, E. / Martin, S.E. / Modrusan, Z. / Piskol, R. / Segal, E. / Venkatanarayan, A. / Ye, X. / Yin, J. / Zhang, L. / Kim, J.S. / Lim, H.S. / Kim, K.P. / Kim, Y.J. / Han, H.S. / Lee, S.J. / Kim, S.T. / Jung, M. / Hong, Y.H. / Noh, Y.S. / Choi, M. / Han, O. / Nowicka, M. / Srinivasan, S. / Yan, Y. / Kim, T.W. / Malek, S. |
External links | Nature / PubMed:33953400 |
Methods | X-ray diffraction |
Resolution | 2 Å |
Structure data | PDB-6xfp: |
Chemicals | ChemComp-V1Y: ChemComp-CL: ChemComp-HOH: |
Source |
|
Keywords | SIGNALING PROTEIN / BRAF Belvarafenib |